TYGIF yields 0.72% · JNJ yields 2.13%● Live data
📍 TYGIF pulled ahead of the other in Year 1
Combined, TYGIF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TYGIF + JNJ for your $10,000?
Toyo Gosei Co.,Ltd. manufactures and sells photosensitive materials for photolithography primarily in Japan. The company offers photosensitive materials primarily for use in the microfabrication of semiconductor integrated circuits and liquid crystal displays, and manufacture of color filters; and a range of high-purity photo acid generators and resins that are used in chemical amplifiers. It is also involved in the recovery of waste solvents and volatile organic compounds through its distillation plants; marketing of various synthetic products; and the supply of electrolytes and ionic liquids used in electric double-layer capacitors. In addition, the company produces aroma chemicals for daily-use products, including shampoos and body soaps, as well as for the flavors of food products; and researches and develops, manufactures, and sells materials for batteries and electrical double layer capacitors. Further, it provides logistics services, such as receiving and shipping systems, storage facilities, and analysis equipment; photosensitive materials for use in the culturing of cells and protein enzymes; and warehousing and goods transportation services. The company was formerly known as Nihon Acetylene Chemical Engineering Co., Ltd. and changed its name to Toyo Gosei Co.,Ltd. in May 1961. Toyo Gosei Co.,Ltd. was founded in 1954 and is headquartered in Tokyo, Japan.
Full TYGIF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.